StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) stock

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3024% above fair value
$1443.50+16.22 (+1.14%)

Close on Nov 13, 2026Market cap $1.36TP/E 46.9Yield 0.43%

Eli Lilly gross margin

Gross margin is gross profit as a percentage of revenue.

Eli Lilly's gross margin for the twelve months ending Sep 30, 2026 was 83.6%. For fiscal 2025 it was 83.0%, against 81.3% the year before. The highest annual figure on record is 83.0% in fiscal 2025.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202583.0%+1.7
FY2024Dec 31, 202481.3%+2.1
FY2023Dec 31, 202379.2%+2.5
FY2022Dec 31, 202276.8%+2.6
FY2021Dec 31, 202174.2%−3.5
FY2020Dec 31, 202077.7%−1.2
FY2019Dec 31, 201978.8%+0.6
FY2018Dec 31, 201878.2%+0.5
FY2017Dec 31, 201777.7%+4.6
FY2016Dec 31, 201673.1%−1.7
FY2015Dec 31, 201574.8%−0.1
FY2014Dec 31, 201474.9%−3.9
FY2013Dec 31, 201378.8%−0.0
FY2012Dec 31, 201278.8%−0.4
FY2011Dec 31, 201179.1%−1.9
FY2010Dec 31, 201081.1%+0.5
FY2009Dec 31, 200980.6%+2.0
FY2008Dec 31, 200878.5%+1.3
FY2007Dec 31, 200777.2%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202683.9%+1.0
Q2 FY2026Jun 30, 202685.8%+1.5
Q1 FY2026Mar 31, 202681.9%−0.6
Q4 FY2025Dec 31, 202582.5%+0.3
Q3 FY2025Sep 30, 202582.9%+1.9
Q2 FY2025Jun 30, 202584.3%+3.5
Q1 FY2025Mar 31, 202582.5%+1.6
Q4 FY2024Dec 31, 202482.2%+1.4
Q3 FY2024Sep 30, 202481.0%+0.6
Q2 FY2024Jun 30, 202480.8%+2.5
Q1 FY2024Mar 31, 202480.9%+4.3
Q4 FY2023Dec 31, 202380.9%+2.1
Q3 FY2023Sep 30, 202380.4%+3.2
Q2 FY2023Jun 30, 202378.3%+0.3
Q1 FY2023Mar 31, 202376.6%+3.2
Q4 FY2022Dec 31, 202278.8%+4.4
Q3 FY2022Sep 30, 202277.3%−1.6
Q2 FY2022Jun 30, 202278.0%+6.9
Q1 FY2022Mar 31, 202273.5%+1.1
Q4 FY2021Dec 31, 202174.4%−2.5
Q3 FY2021Sep 30, 202178.9%+2.0
Q2 FY2021Jun 30, 202171.0%−6.8
Q1 FY2021Mar 31, 202172.4%−6.9
Q4 FY2020Dec 31, 202076.9%−2.1
Q3 FY2020Sep 30, 202076.9%−1.7
Q2 FY2020Jun 30, 202077.8%−2.3
Q1 FY2020Mar 31, 202079.3%+1.6
Q4 FY2019Dec 31, 201979.0%−0.9
Q3 FY2019Sep 30, 201978.5%+0.3
Q2 FY2019Jun 30, 201980.0%+2.1
Q1 FY2019Mar 31, 201977.6%+1.1
Q4 FY2018Dec 31, 201880.0%+6.7
Q3 FY2018Sep 30, 201878.3%+6.3
Q2 FY2018Jun 30, 201877.9%+4.9
Q1 FY2018Mar 31, 201876.5%+2.3
Q4 FY2017Dec 31, 201773.3%−1.3
Q3 FY2017Sep 30, 201772.0%–
Q2 FY2017Jun 30, 201773.0%–
Q1 FY2017Mar 31, 201774.2%–
Q4 FY2016Dec 31, 201674.6%–

More Eli Lilly figures

See a number that looks wrong?